Intriguingly, CCK-8 assays revealed that PAX3 knockdown increased the sensitivity of U251 (Figure 8O) and U87 (Figure 8P) cells to vorinostat, highlighting a potential role of PAX3 in modulating drug sensitivity in glioma cells. This evidence concerns the gene PAX3 and central nervous system cancer.